Αρχειοθήκη ιστολογίου

Παρασκευή 21 Ιουλίου 2017

Austin biotech company loses CEO as disease treatments work through regulatory process

David Lowe helped guide Aeglea through the initial phases of the regulatory process, and its 2016 IPO that raised millions of dollars to develop treatments for cancer and rare genetic diseases. (Source: bizjournals.com Health Care:Biotechnology headlines)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2vKh01E
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader